The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Other Motor Neuron Disord
; 2(3): 153-8, 2001 Sep.
Article
em En
| MEDLINE
| ID: mdl-11771772
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Riluzol
/
Esclerose Lateral Amiotrófica
Tipo de estudo:
Clinical_trials
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2001
Tipo de documento:
Article